Robert C. Nowinski
15Patents
8h-index
16Co-inventors
69Inventor score
Filing activity: Nov 10, 1983 → Apr 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4511478A | Polymerizable compounds and methods for preparing synthetic polymers that integrally contain polypeptides | Emerging Cross-Sectional Technologies | 106 | Expired |
| US4749647A | Polymerization-induced separation assay using recognition pairs | Emerging Cross-Sectional Technologies | 75 | Expired |
| US4752638A | Synthesis and use of polymers containing integral binding-pair members | Emerging Cross-Sectional Technologies | 41 | Expired |
| US4609707A | Synthesis of polymers containing integral antibodies | Emerging Cross-Sectional Technologies | 34 | Expired |
| US9005579B2 | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria | Physics | 16 | Active |
| US4711840A | Polymerization-induced separation immunoassays | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4843010A | Polymerization-induced separation immunoassays | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5068178A | Method of enhancing direct immunofluorescence staining of cells | Emerging Cross-Sectional Technologies | 15 | Expired |
| US9499594B2 | Biofilm prevention, disruption and treatment with bacteriophage lysin | Emerging Cross-Sectional Technologies | 5 | Active |
| US9731010B2 | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria | Physics | 2 | Active |
| US5514542A | Methods for propagating retrovirus for use in antibody assays | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9889181B2 | Bacteriophage lysin and antibiotic combinations against gram positive bacteria | Emerging Cross-Sectional Technologies | 1 | Active |
| US10813983B2 | Bacteriophage lysin and antibiotic combinations against gram positive bacteria | Emerging Cross-Sectional Technologies | 0 | Active |
| US10588971B2 | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria | Physics | 0 | Active |
| US11524046B2 | Biofilm prevention, disruption and treatment with bacteriophage lysin | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.